Advancing cancer research through 3D cell culture models

TL;DR

This paper reviews how 3D cell culture models can better mimic cancer's complexity compared to traditional 2D methods, improving research and treatment understanding.

Contribution

The paper provides a comprehensive review of 3D cell culture techniques in oncology, highlighting their advantages over monolayer models.

Findings

3D cell culture models better replicate tumor biology and heterogeneity.

Techniques like scaffolds and microfluidic platforms enhance 3D modeling.

3D models offer improved applications for studying cancer progression and drug resistance.

Abstract

Cancer is a multifactorial disease with cellular proliferative molecular networks and immune evasion properties. The well-known cancer intra- and inter-tumoral heterogeneity presents a notable limitation of the current histological and diagnostic techniques. Thus, biasing the risk of invasiveness and restricting its broader application in oncology in prognostic, survival, and treatment response differences between patients. Monolayer cell cultures have been a consistent in vitro model in cancer research throughout time. However, this system fails to replicate the complex pathogenesis of this disease, as key mechanisms underlying initiation, metastasis, drug resistance, and recurrence remain poorly understood. 3D culture models are presented as the most suitable model to better reflect the patient's tumor development. Some methods to introduce the third dimension into cell cultures is by promoting cell-cell interactions to give 3D cell structures, using scaffolds to promote growth beyond monolayers and introducing microfluidic platforms to the system. The present review provides an overview of different techniques to develop 3D culture models in oncology, the advantages compared between monolayer cell cultures, their applications, limitations, and applicability in oncology research.

See also the graphical abstract(Fig. 1).

Figures